NCT07555847

Brief Summary

The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. The study will also examine how true kinesiotaping compares with sham (placebo) taping and with exercise alone in improving tremor frequency, grip strength, fine motor skills, motor symptoms, daily living activities, and quality of life. Adults aged 18-80 with Parkinson's disease and hand tremor will be randomly assigned to one of three groups: Kinesiotaping + Exercise Group: Participants will receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist for 4 weeks (twice weekly), in addition to a home program of strengthening and stretching exercises. Sham Taping + Exercise Group: Participants will receive a placebo taping without tension that does not target specific muscles, along with the same exercise program. Exercise-Only Group: Participants will complete the same home-exercise program without any taping. Researchers will compare the three groups to see whether kinesiotaping provides additional benefits beyond exercise and whether it performs better than sham taping. Tremor frequency will be measured using an Apple Watch device, and hand strength, dexterity, motor symptoms, and quality of life will be assessed using validated clinical scales.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 29, 2026

Completed
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

April 14, 2026

Last Update Submit

April 21, 2026

Conditions

Keywords

KinesiotapingKinesiologic tapingParkinson tremorHand tremorUpper extremity tremorForearm extensor tapingSham tapingExercise therapyHome exercise programMDS-UPDRSPDQ-39Nine Hole Peg TestGrip strengthApple Watchtremor measurement

Outcome Measures

Primary Outcomes (1)

  • Tremor Frequency (Hz)

    Change in dominant tremor frequency measured using Apple Watch sensors (accelerometer and gyroscope) during a standardized 60-second recording period. Lower frequency values indicate improvement in tremor severity.

    Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)

Secondary Outcomes (7)

  • Hand Grip Strength (kg)

    Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)

  • Pinch Strength (kg)

    Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)

  • Fahn-Tolosa-Marin Tremor Rating Scale Score

    Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)

  • Nine-Hole Peg Test

    Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)

  • MDS-UPDRS Part III Score

    Time Frame: Baseline (Day 0), End of treatment (Week 4), and Follow-up (Week 8; 4 weeks after treatment completion)

  • +2 more secondary outcomes

Study Arms (3)

Kinesiotaping + Exercise

EXPERIMENTAL

Participants receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist twice weekly for 4 weeks, in addition to a daily home-based strengthening and stretching exercise program.

Other: Therapeutic KinesiotapingBehavioral: Home Exercise Program

Sham Taping + Exercise

SHAM COMPARATOR

Participants receive sham taping without therapeutic tension and without following muscle-fiber orientation, applied twice weekly for 4 weeks, along with the same daily home-based exercise program

Other: Sham TapingBehavioral: Home Exercise Program

Exercise Only

ACTIVE COMPARATOR

Participants complete the standardized daily home-based strengthening and stretching exercise program for 4 weeks, with no taping applied

Behavioral: Home Exercise Program

Interventions

Kinesiotaping applied to forearm extensor muscles with therapeutic tension and direction, twice weekly for 4 weeks

Kinesiotaping + Exercise

Placebo taping applied without therapeutic tension and without muscle alignment, twice weekly for 4 weeks

Sham Taping + Exercise

Daily strengthening and stretching exercises targeting forearm muscles, performed for 4 weeks.

Exercise OnlyKinesiotaping + ExerciseSham Taping + Exercise

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic Parkinson's disease
  • Hoehn and Yahr stage 1-4
  • Presence of hand tremor
  • Mini-Mental State Examination (MMSE) score ≥ 23
  • Stable medical treatment for at least 3 months prior to enrollment and no planned changes during the study period
  • Age between 18 and 80 years
  • Ability to understand and provide written informed consent

You may not qualify if:

  • Diagnosis of essential tremor or tremor due to causes other than Parkinson's disease
  • Advanced motor impairment (severe bradykinesia or dyskinesia)
  • History of allergic reaction to kinesiotaping materials
  • Presence of other neurological disorders causing tremor (e.g., ALS, multiple sclerosis, cerebellar disorders)
  • Severe psychiatric disorders (e.g., major depression, psychosis, severe anxiety)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital

Istanbul, Uskudar, 34668, Turkey (Türkiye)

Location

Related Publications (6)

  • Giray E, Karali-Bingul D, Akyuz G. The Effectiveness of Kinesiotaping, Sham Taping or Exercises Only in Lateral Epicondylitis Treatment: A Randomized Controlled Study. PM R. 2019 Jul;11(7):681-693. doi: 10.1002/pmrj.12067. Epub 2019 Mar 28.

    PMID: 30609278BACKGROUND
  • Dai H, Lin H, Lueth TC. Quantitative assessment of parkinsonian bradykinesia based on an inertial measurement unit. Biomed Eng Online. 2015 Jul 12;14:68. doi: 10.1186/s12938-015-0067-8.

    PMID: 26164814BACKGROUND
  • Shahien M, Elaraby A, Gamal M, Abdelazim E, Abdelazeem B, Ghaith HS, Negida A. Physical therapy interventions for the management of hand tremors in patients with Parkinson's disease: a systematic review. Neurol Sci. 2023 Feb;44(2):461-470. doi: 10.1007/s10072-022-06420-1. Epub 2022 Oct 7.

    PMID: 36205810BACKGROUND
  • Mahadevan N, Demanuele C, Zhang H, Volfson D, Ho B, Erb MK, Patel S. Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device. NPJ Digit Med. 2020 Jan 15;3:5. doi: 10.1038/s41746-019-0217-7. eCollection 2020.

    PMID: 31970290BACKGROUND
  • Bravi R, Quarta E, Cohen EJ, Gottard A, Minciacchi D. A little elastic for a better performance: kinesiotaping of the motor effector modulates neural mechanisms for rhythmic movements. Front Syst Neurosci. 2014 Sep 25;8:181. doi: 10.3389/fnsys.2014.00181. eCollection 2014.

    PMID: 25309355BACKGROUND
  • Capecci M, Serpicelli C, Fiorentini L, Censi G, Ferretti M, Orni C, Renzi R, Provinciali L, Ceravolo MG. Postural rehabilitation and Kinesio taping for axial postural disorders in Parkinson's disease. Arch Phys Med Rehabil. 2014 Jun;95(6):1067-75. doi: 10.1016/j.apmr.2014.01.020. Epub 2014 Feb 5.

    PMID: 24508531BACKGROUND

MeSH Terms

Conditions

Parkinson DiseaseTremor

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mehmet Akif Guler

    University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors will be blinded. The care provider applying kinesiotaping cannot be blinded due to the nature of the intervention
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-arm parallel design comparing kinesiotaping plus exercise, sham taping plus exercise, and exercise alone in individuals with Parkinson's disease and hand tremor.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical Medicine and Rehabilitation Specialist

Study Record Dates

First Submitted

April 14, 2026

First Posted

April 29, 2026

Study Start

March 1, 2025

Primary Completion

November 1, 2025

Study Completion

January 1, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to patient privacy concerns, institutional policies, and the lack of a predefined data-sharing infrastructure for this single-center academic study.

Locations